On ECHEMI
Home > Drugs > GREEN CROSS China Biological Products Co., Ltd.
GREEN CROSS China Biological Products Co., Ltd.
  • Founded in:

    1995-10-18
  • Country:

    China China
  • Address:

    No. 26, Guoqing East Road, Economic and Technological Development Zone, Huainan City, Anhui Province
  • Tax NO.:

    913404006103799005
  • Registered Funds:

    158.54702 million yuan
  • Email:

Related Drugs
Hepatitis B immune globulin
Molecular weight of human hepatitis B immunoglobulin.
Name Description Content CAS NO. Registered Holders
Human Hepatitis B immunoglobulin BRP

Contains high titer hepatitis B surface antibodies, which can specifically bind to the corresponding antigen to play a role in passive immunity

More

Contains high titer hepatitis B surface antibodies, which can specifically bind to the corresponding antigen to play a role in passive immunity

0
Human coagulation factor VIII
Main ingredients: Human coagulation factor VIII from healthy human plasma Excipients: Sodium citrate, glycine, calcium chloride, sodium chloride
Name Description Content CAS NO. Registered Holders
Human Factor IIA(FIIA) ELISA

In the process of endogenous blood coagulation, as a cofactor, in the presence of Ca2+ and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, as a cofactor, in the presence of Ca2+ and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

0
Trisodium citrate dihydrate

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

6132-04-3 30
Glycine

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

56-40-6 27
Calcium chloride

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

10043-52-4 27
Sodium chloride

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

7647-14-5 43
Human coagulation factor VIII
Main ingredients: Human coagulation factor VIII from healthy human plasma Excipients: Sodium citrate, glycine, calcium chloride, sodium chloride
Name Description Content CAS NO. Registered Holders
Human Factor IIA(FIIA) ELISA

In the process of endogenous blood coagulation, as a cofactor, in the presence of Ca2+ and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, as a cofactor, in the presence of Ca2+ and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

0
Trisodium citrate dihydrate

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

6132-04-3 30
Glycine

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

56-40-6 27
Calcium chloride

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

10043-52-4 27
Sodium chloride

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

More

In the process of endogenous blood coagulation, coagulation factor VIII acts as a cofactor, and in the presence of Ca21 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2%-2.5%.

7647-14-5 43
Human fibrinogen
The main ingredient of this product is human fibrinogen.
Name Description Content CAS NO. Registered Holders
Human Fibrinogen

During the coagulation process, fibrinogen is enzymatically hydrolyzed by thrombin into fibrin. Under the action of fibrin-stabilizing factor (FXIII), solid fibrin is formed, which plays an effective hemostatic role.

More

During the coagulation process, fibrinogen is enzymatically hydrolyzed by thrombin into fibrin. Under the action of fibrin-stabilizing factor (FXIII), solid fibrin is formed, which plays an effective hemostatic role.

0
Human fibrinogen
The main ingredient of this product is human fibrinogen.
Name Description Content CAS NO. Registered Holders
Human Fibrinogen

During the coagulation process, fibrinogen is enzymatically hydrolyzed by thrombin into fibrin. Under the action of fibrin-stabilizing factor (FXIII), solid fibrin is formed, which plays an effective hemostatic role.

More

During the coagulation process, fibrinogen is enzymatically hydrolyzed by thrombin into fibrin. Under the action of fibrin-stabilizing factor (FXIII), solid fibrin is formed, which plays an effective hemostatic role.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.